lunes, 17 de octubre de 2016

NHLBI Funding & Research Opportunities and Announcements for October 07, 2016

NHLBI_Standard_Sig_Logo_RGB - New

Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Notices:
          NIH Offers Niche Assessment Program to SBIR and STTR Phase I Awardees
          (NOT-OD-16-144) National Institutes of Health
            NIH Operates Under a Continuing Resolution
            (NOT-OD-17-001) National Institutes of Health
              Notice of Information Regarding the "Announcement of Antimicrobial Resistance 
              Rapid, Point-of-Care Diagnostic Test Challenge Competition"
              (NOT-OD-17-004) National Institutes of Health
                Optional Electronic Submission Method to Request to Submit An Unsolicited 
                Application That Will Exceed $500,000 In Direct Costs
                (NOT-OD-17-005) National Institutes of Health
                  Request for information (RFI): Including Preprints and Interim Research Products 
                  in NIH Applications and Reports
                  (NOT-OD-17-006) National Institutes of Health
                          Requests for Applications:
                            BD2K Support for Meetings of Data Science Related Organizations (U13)
                            (RFA-CA-16-020)
                                Program  Announcements:
                                    Secondary Analyses of Existing Datasets in Heart, Lung, and Blood Diseases 
                                    and Sleep Disorders (R21)
                                    (PAR-17-004)
                                    National Heart, Lung, and Blood Institute
                                    Application Receipt/Submission Date(s): New applications: February 24, 2017; 
                                    February 23, 2018; February 22, 2019, by 5:00 PM local time of application 
                                    organization.
                                      In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse 
                                      Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01)
                                      (PAR-17-005)

                                      No hay comentarios:

                                      Publicar un comentario